Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective

Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometric pattern without high-resolution computed tomography (HRCT) evidence of parenchymal opacities. Computed tomography and microCT analysis show abundant small...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Dalila Cavallaro, Marco Guerrieri, Stefano Cattelan, Gaia Fabbri, Sara Croce, Martina Armati, David Bennett, Antonella Fossi, Luca Voltolini, Luca Luzzi, Alberto Salvicchi, Piero Paladini, Adriano Peris, Miriana d’Alessandro, Paolo Cameli, Elena Bargagli, Tuscany Transplant Group, Laura Bergantini
Format: Artikel
Sprache:English
Veröffentlicht: MDPI AG 2022-12-01
Schriftenreihe:Biomedicines
Schlagworte:
Online Zugang:https://www.mdpi.com/2227-9059/10/12/3277
_version_ 1827641604767219712
author Dalila Cavallaro
Marco Guerrieri
Stefano Cattelan
Gaia Fabbri
Sara Croce
Martina Armati
David Bennett
Antonella Fossi
Luca Voltolini
Luca Luzzi
Alberto Salvicchi
Piero Paladini
Adriano Peris
Miriana d’Alessandro
Paolo Cameli
Elena Bargagli
Tuscany Transplant Group
Laura Bergantini
author_facet Dalila Cavallaro
Marco Guerrieri
Stefano Cattelan
Gaia Fabbri
Sara Croce
Martina Armati
David Bennett
Antonella Fossi
Luca Voltolini
Luca Luzzi
Alberto Salvicchi
Piero Paladini
Adriano Peris
Miriana d’Alessandro
Paolo Cameli
Elena Bargagli
Tuscany Transplant Group
Laura Bergantini
author_sort Dalila Cavallaro
collection DOAJ
description Bronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometric pattern without high-resolution computed tomography (HRCT) evidence of parenchymal opacities. Computed tomography and microCT analysis show abundant small airway obstruction, starting from the fifth generation of airway branching and affecting up to 40–70% of airways. The pathogenesis of BOS remains unclear. It is a multifactorial syndrome that leads to pathological tissue changes and clinical manifestations. Because BOS is associated with the worst long-term survival in LTx patients, many studies are focused on the early identification of BOS. Markers may be useful for diagnosis and for understanding the molecular and immunological mechanisms involved in the onset of BOS. Diagnostic and predictive markers of BOS have also been investigated in various biological materials, such as blood, BAL, lung tissue and extracellular vesicles. The aim of this review was to evaluate the scientific literature on markers of BOS after lung transplant. We performed a systematic review to find all available data on potential prognostic and diagnostic markers of BOS.
first_indexed 2024-03-09T17:17:11Z
format Article
id doaj.art-5ccf859e1eee4c4aa2d775443c2ca634
institution Directory Open Access Journal
issn 2227-9059
language English
last_indexed 2024-03-09T17:17:11Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj.art-5ccf859e1eee4c4aa2d775443c2ca6342023-11-24T13:29:56ZengMDPI AGBiomedicines2227-90592022-12-011012327710.3390/biomedicines10123277Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future PerspectiveDalila Cavallaro0Marco Guerrieri1Stefano Cattelan2Gaia Fabbri3Sara Croce4Martina Armati5David Bennett6Antonella Fossi7Luca Voltolini8Luca Luzzi9Alberto Salvicchi10Piero Paladini11Adriano Peris12Miriana d’Alessandro13Paolo Cameli14Elena Bargagli15Tuscany Transplant Group16Laura Bergantini17Respiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyThoracic Surgery Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, 50134 Firenze, ItalyLung Transplant Unit, Department of Medical, Surgical and Neuro Sciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, ItalyThoracic Surgery Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, 50134 Firenze, ItalyLung Transplant Unit, Department of Medical, Surgical and Neuro Sciences, Azienda Ospedaliero-Universitaria Senese, University of Siena, 53100 Siena, ItalyOrganizzazione Toscana Trapianti, Regione Toscana, 50134 Firenze, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyRespiratory Disease and Lung Transplant Unit, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, 53100 Siena, ItalyBronchiolitis obliterans syndrome (BOS) is the most common form of CLAD and is characterized by airflow limitation and an obstructive spirometric pattern without high-resolution computed tomography (HRCT) evidence of parenchymal opacities. Computed tomography and microCT analysis show abundant small airway obstruction, starting from the fifth generation of airway branching and affecting up to 40–70% of airways. The pathogenesis of BOS remains unclear. It is a multifactorial syndrome that leads to pathological tissue changes and clinical manifestations. Because BOS is associated with the worst long-term survival in LTx patients, many studies are focused on the early identification of BOS. Markers may be useful for diagnosis and for understanding the molecular and immunological mechanisms involved in the onset of BOS. Diagnostic and predictive markers of BOS have also been investigated in various biological materials, such as blood, BAL, lung tissue and extracellular vesicles. The aim of this review was to evaluate the scientific literature on markers of BOS after lung transplant. We performed a systematic review to find all available data on potential prognostic and diagnostic markers of BOS.https://www.mdpi.com/2227-9059/10/12/3277biomarkerslung transplantbronchiolitis obliterans syndrome
spellingShingle Dalila Cavallaro
Marco Guerrieri
Stefano Cattelan
Gaia Fabbri
Sara Croce
Martina Armati
David Bennett
Antonella Fossi
Luca Voltolini
Luca Luzzi
Alberto Salvicchi
Piero Paladini
Adriano Peris
Miriana d’Alessandro
Paolo Cameli
Elena Bargagli
Tuscany Transplant Group
Laura Bergantini
Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
Biomedicines
biomarkers
lung transplant
bronchiolitis obliterans syndrome
title Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
title_full Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
title_fullStr Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
title_full_unstemmed Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
title_short Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective
title_sort markers of bronchiolitis obliterans syndrome after lung transplant between old knowledge and future perspective
topic biomarkers
lung transplant
bronchiolitis obliterans syndrome
url https://www.mdpi.com/2227-9059/10/12/3277
work_keys_str_mv AT dalilacavallaro markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT marcoguerrieri markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT stefanocattelan markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT gaiafabbri markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT saracroce markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT martinaarmati markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT davidbennett markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT antonellafossi markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT lucavoltolini markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT lucaluzzi markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT albertosalvicchi markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT pieropaladini markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT adrianoperis markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT mirianadalessandro markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT paolocameli markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT elenabargagli markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT tuscanytransplantgroup markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective
AT laurabergantini markersofbronchiolitisobliteranssyndromeafterlungtransplantbetweenoldknowledgeandfutureperspective